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Abstract.  The myosin 20,000-D regulatory light chain 
(RLC) has a central  role in smooth muscle contrac- 
tion.  Previous work has suggested either the presence 
of two RLC isoforms, one specific for nonmuscle and 
one specific for smooth muscle, or the absence of a 
true smooth muscle-specific isoform, in which in- 
stance smooth muscle cells would use nonmuscle iso- 
forms.  To address this issue directly, we have isolated 
rat RLC cDNAs and corresponding genomic se- 
quences of two smooth muscle RLC based on homol- 
ogy to the amino acid sequence of the chicken gizzard 
RLC. These cDNAs are highly homologous in their 
amino acid coding regions and contain unique 3'-un- 
translated  regions.  RNA analyses of rat tissue using 
these unique 3'-untranslated  regions revealed that their 
expression is differentially regulated.  However, one 
eDNA (RLC-B), predominantly a  nonmuscle isoform, 
based on abundant expression in nonmuscle tissues in- 
cluding brain,  spleen, and lung,  is easily detected in 
smooth muscle tissues.  The other cDNA (RLC-A;  see 
Taubman,  M., J.  W.  Grant,  and B.  Nadal-Ginard. 
1987. J.  Cell Biol. 104:1505-1513) was detected in a 
variety of nonmuscle,  smooth muscle, and  sarcomeric 
tissues.  RNA analyses comparing expression of both 
RLC genes with the actin gene family and  smooth 
muscle specific o~-tropomyosin  demonstrated that nei- 
ther RLC gene was strictly smooth muscle specific. 
RNA analyses of cell lines demonstrated that both of 
the RLC genes are expressed in a  variety of cell types. 
The complete genomic structure of RLC-A and close 
linkage to RLC-B is described. 
M 
YOSIN, the major contractile element of the thick 
filament,  is  composed of two identical  200-kD 
heavy chains and two sets of light chains,  the 20- 
kD regulatory and the  17- and 23-kD alkalai  light  chains. 
The 20-kD regulatory light chain (RLC) ~  of smooth muscle 
contributes significantly  to the functional  characteristics  of 
smooth muscle contraction and myosin structure (2,  17). In 
vertebrates, phosphorylation of RLC by myosin light chain 
kinase increases active tension in intact smooth muscle tis- 
sue and in actin-activated  myosin ATPase activity in vitro 
(2).  Phosphorylation of the RLC occurs at several sites in- 
cluding  serine-19,  the adjacent threonine-20,  threonine-9, 
and serine-2 (4, 10, 18, 19). The RLC is involved in filament 
structure and conformation by interactions  with the globular 
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head of the myosin heavy chain and the alkalai light chains 
(17). In vitro filament assembly, conformation of the myosin, 
stability and the solubility characteristics  of nonmuscle and 
smooth muscle myosin are directly influenced by phosphory- 
lation of the RLC (8, 9, 23, 49, 50).  Recent data suggest a 
direct contribution of RLC pbosphorylation on both myosin 
conformation  and its ATP activity (51). 
Protein sequence data has demonstrated distinct isoforms 
of the RLC for smooth muscle and sarcomeric tissues  (27, 
29). A separate isoform for a nonmuscle RLC has not been 
identified,  although  a  20-kD phosphorylated myosin light 
chain exists in a variety of tissues including fibroblasts, plate- 
lets,  intestinal  brush border, and pancreatic  acinar cells (1, 
3, 5, 6, 8, 14, 53). The smooth muscle and fibroblast 20-kD 
RLC co-migrate on isoelectric focusing gels (6). The pres- 
ence of at least two different isoforms has been reported for 
vascular, uterine smooth muscles (11, 14) and pancreatic aci- 
nar cells (5),  though,  precise identification  of isoforms is 
complicated by the potential  for shifts  caused by multiple 
phosphorylations. 
The sequence analyses of cDNAs and the corresponding 
genes isolated for mammalian  skeletal,  cardiac,  and smooth 
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different  gene (13, 16, 24, 25, 29, 35, 46, 59). The sarcomeric 
regulatory light chains have strict developmental and tissue 
specific regulation (20, 24, 57). Mammalian nonsarcomeric 
RLC cDNAs  (RLC-A) have been isolated from rat aortic 
smooth muscle cells and human umbilical vein eDNA li- 
braries (25, 46).  Both cDNAs are expressed in nonmuscle 
cell lines and smooth muscle tissues making their character- 
ization as smooth muscle specific isoforms difficult. 
The presence of similar RLC mRNAs in diverse cell types 
other than smooth muscle tissues suggests two possible alter- 
natives. On the one hand, it is possible that highly homolo- 
gous RLC isoforms exist that are specific for nonmuscle and 
smooth muscle cells, respectively, and that both types are ex- 
pressed in smooth muscle cells. On the other hand, it is pos- 
sible that no true smooth muscle isoform exists and that 
smooth  muscle tissue  expresses  "generic" nonsarcomeric 
isoforms. To distinguish between these two alternatives, we 
have sought to define and characterize the set of RLC iso- 
forms expressed in smooth muscle and nonmuscle tissues. 
The  approach  has  been  to  screen,  different  eDNA  and 
genomic libraries and to perform RNA analyses of rat tissues 
and cell lines. In addition to the previously described eDNA 
(RLC-A) (46), we have identified and characterized cDNAs 
corresponding to a different  nonsarcomeric isoform (RLC-B). 
The two rat RLC genes represented by these clones are ex- 
pressed in both smooth muscle and nonmuscle tissues. How- 
ever, their expression is differentially regulated. One of the 
isoforms is predominantly a nonmuscle isoform that is ex- 
pressed at high levels particularly in brain and spleen and has 
a very low level of expression in sarcomeric tissues and myo- 
genic cell lines. The other RLC isoform is found in high lev- 
els in all tissues. Neither isoform is smooth muscle-specific 
despite their significant homology to the isoform expressed 
in chicken gizzard (27). 
Materials and Methods 
Materials 
Restriction endonucleases and DNA modifying  enzymes were purchased 
from either New  England BioLabs (Beverly, MA) or Bethesda Research 
Laboratories  (Gaithersburg,  MD).  Radioisotopes  were  purchased from 
Amersham Corp. (Arlington Heights,  IL) and were incorporated into iso- 
lated DNA by either nick translation or end labeled by standard methods 
(28).  DNA sequencing  was performed using reagents from New England 
Biolabs or  Promega Biotee (Madison, WI).  Autoradiography was  per- 
formed using Kodak X-OMAT film and Picker-Max intensifying  screens. 
Screening of cDNA and Genomic Libraries 
Approximately  5  x  105 recombinants of a  rat liver eDNA library con- 
structed in kgt-ll  (provided  Dr.  Mike Meukler,  Washington University 
School of Medicine) and a brain eDNA library constructed in kgt-10 were 
screened by duplicate lift hybridization at 42°C and 25 % formamide as de- 
scribed previously  (46).  A rat liver genomic library generated by partial 
digestion of total rat liver genomic DNA by Sau IIIA and ligation into 
EMBL-3B was generously provided by Dr. Richard Hynes (Massachusetts 
Institute of Technology).  Approximately  1.2  x  106 recombinants were 
screened.  Both eDNA and genomie libraries were probed with the 935 nt 
RLC-2 eDNA (46), washed in 0.2  x  SSC (1  × =  0.15 M NaCI and 0.015 
M Na citrate) and 0.1% SDS at 42°C and exposed for autoradiography.  Posi- 
tive duplicate  plaques were isolated and purified to homogeneity  by serial 
plating. 
Characterization and Restriction Mapping of cDNA 
and Genomic Clones 
Phage DNA from the purified plaques was harvested, digested with a series 
of restriction enzymes,  and 10/~g of each digest was size separated on 1% 
agarose  gel and blotted onto nitrocellulose  (44).  Hybridization of these 
blots of the genornic clones were performed at 37°C and without formamide 
in the hybridization buffer using an oligonucleotide  (39-mer)  representing 
the sequence in the 5'-untranslated region of the RLC-A (46) endlabeled 
with a[32P]ATE  After autoradiographic exposure  the blots were washed 
with 0.01 4  SSC at 90°C to remove the signal and a repeat hybridization 
was performed using a 93 nucleotide  Pst I-Eco RI fragment derived from 
the 3'-untranslated  region of the RLC-A eDNA.  Similarly,  eDNA clones 
were selected  for sequence evaluation based on positive hybridization sig- 
nals to the entire coding region of the RLC-A cDNA and negative hybridiza- 
tion with the probes representing the untranslated regions. 
DNA Sequencing 
The eDNA inserts were isolated and were subcloned into plasmid vectors 
(either pUC-18 or psp-72) or into the phage vectors M13-mp18 or -mpl9 
and the nueleotide sequence determined by the dideoxy-chain  termination 
method (46). Both strands were analyzed using oligonueleotides  to overlap 
sequences in both directions. Sequence analysis was performed using a Dig- 
ital VAX minicomputer and Intelligenetics  software. 
Cellular RNA A nalysis 
Total cellular RNA was isolated by a modification of Chirgwin (7). Tissues 
were removed from rats and immediately frozen in liquid nitrogen.  Homog- 
enized tissue was suspended in 4 M guanidium isothiocyanate lysis buffer 
(pH 7.0), and sheared through a 22 gauge needle. The RNA was precipitated 
by layering on a 5.7-M cesium chloride cushion and centrifugation in a rotor 
(SW41; Beckman Instruments, Inc., Palo Alto, CA). The RNA pellet was 
washed with 70% ethanol and resuspended in water. RNA blot analysis was 
performed by site-fractionating  5 t~gm  of RNA on a 1.5 % agarose/formalde- 
hyde denaturing gels for 15 h followed by transfer to nitrocellulose  or nylon 
membranes for hybridizations.  Probes for RNA analyses  were generated 
using the Riboprobe system in which antisense cRNA copies of linearized 
plasmids were generated using either the "1"7 or Sp6 RNA polymerase with 
incorporated a[32P]CTP. Hybridization of RNA blots were performed as 
previously  described (46) with 50% formamide,  5x  SSC 0x  =  0.15 M 
NaCI, 0.015 sodium citrate), 2x  Denhardt's solution, 0.1% SDS, 0.025 M 
sodium phosphate, and 50 mg/ml of salmon sperm DNA at a temperature 
of 60°C.  Blots were washed at a final stringency  of 70°C and 0.24  SSC 
and exposed  for autoradiography. 
Cell Culture 
The H4TG rat liver cell line was grown in modified eagle's media and 10% 
horse serum. The mouse C2C12 skeletal  myoblast RNA was provided by 
Dr. J. Billadello (Washington University School of Medicine). The rat pan- 
creatic acinar cell line (AR42J) poly-A+ mRNA was provided by Dr. M. 
Lowe (Washington University School of Medicine). Rat aortic smooth mus- 
cle cells (RASM) were grown as previously described (47). Subculture pas- 
sages  10-16 were used for all experiments.  These cells have been shown 
morphologically  to be smooth muscle, with a characteristic spindle shape 
and actin-myosin stress fibers (47).  Cells were grown in 10% beat-inacti- 
vated calf serum in DME supplemenlead with 100/zg/ml streptomycin  and 
100 U/m/penicillin. Quiescence was induced by incubation with DME sup- 
plemented with 0.4%  fetal calf serum. RASM grown in these conditions 
incorporated <10% of [3H]thymidine when compared to RASM grown in 
10% FCS (46). 
Results 
Isolation  of a cDNA Clone Coding for a Novel RLC 
A total of 11 clones were isolated by screening the liver kgt- 
11  library and the brain kgt-10 library using the rat aortic 
smooth muscle cell RLC-2 eDNA (named RLC-A in this re- 
port; reference 46) as described in Materials and Methods. 
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Figure L Partial restriction maps 
of  the ),GT-10  and 11 cDNA  clones 
isolated from rat liver (L-9) and 
brain (B-4) containing RLC-B and 
the RLC-A clone (R-2) isolated 
from  RASM cells.  The striped 
box  represents  the  amino  acid 
coding region and the lines the 5' 
and 3' untranslated regions. The 
amino acid start codon (ATG) is 
represented at the 5' end above 
each coding region box and the 
termination codon is denoted by a 
TGA below the end of each cod- 
ing region box. The sites of poly- 
A+  tails  are  denoted  by  the 
AAAAA region the B-4 and R-2 
clones. Restriction endonuclease 
sites  are  shown by the  vertical 
lines headed by the following abbreviations: R, Eco RI; St, Sty I; Sma, Sma I; N, Nco I; Rs, Rsa I; P, Pst I; H, Hind III; A, Alu I. The 
specific regions used to generate cRNA probes for Northern analysis are denoted by the lines underneath the corresponding part of the 
eDNA.  These are coding region (//-//); RLC-B 3' untranslated regions (\\-\\); and the RLC-A 3' untranslated region (~,). 
One clone from each library was >900 nucleotides in length 
and contained a different restriction map from RLC-A (refer- 
ence 47; Fig. 1). The nucleotide sequences of  these two clones 
(Fig. 2 a) are overlapping and contain an open reading frame 
of 545 nucleotides beginning with an ATG at position 15. A 
577-bp 3'-untranslated region and an 18 nucleotide poly-A+ 
tail are present. Comparison of the derived amino acid se- 
quence to the chicken gizzard myosin RLC (27, 30) confirms 
that these rat cDNA clones are myosin regulatory light chains 
of smooth muscle type (Fig. 2 b). 
The Two Rat RLC Genes Are Highly Homologous 
The homology between  the  two  rat RLC  proteins  at  the 
amino acid level is 97 %. The five amino acid differences are 
conservative (Fig. 2 c). As denoted by the colons between 
the sequences in Fig.  2 a, the nucleotide sequences of the 
amino acid coding regions are 96%  homologous. No sig- 
nificant homology exists in the 3'-untranslated regions. None 
of the clones evaluated to date contain more sequence infor- 
mation representing the 5'-untranslated region. A polyade- 
nylation signal (AATAAA) is located at nucleotide 1056 and 
differs from the signal described from RLC-A (AATTAAA). 
In addition, a 47 nucleotide direct repeat is found in the 3'- 
untranslated region of RLC-B beginning 40 nucleotides after 
the stop codon (Fig. 2 b). The repeat is present five times 
with the homology among the repeats of 91%/73 %/91%/87%, 
respectively, using the  first sequence as  the reference se- 
quence. These repeats have also been found in a processed 
pseudogene of RLC-B (unpublished data) making it unlikely 
that the repeats represent a cloning artifact. 
The Two RLC Genes Represented by RLC-A and 
RLC-B cDNA Clones Exhibit Different 1Issue-specific 
Patterns of Expression 
The high degree of sequence identity between the two mam- 
malian RLC mRNA isoforms and each of them to the chicken 
gizzard RLC protein sequence suggests that they could rep- 
resent smooth muscle myosin RLCs. RNA blot analyses of 
total cellular RNA isolated from rat tissues was performed 
with the specific Y-untranslated regions of both RLC-A and 
-B cDNAs as probes and compared to the hybridization pat- 
tern of a coding region probe. The autoradiogram in Fig. 3 
a  shows the hybridization pattern when the 524 nucleotide 
Pst I/Eco RI 3'-untranslated region cRNA probe of RLC-B 
is used. RLC-B mRNA is most abundant in spleen, brain, 
lung, and uterus.  Longer exposures of the blots shows the 
RLC-B mRNA  to be present in liver,  kidney,  aorta,  and 
cardiac muscle (see Fig. 3 a). The hybridization pattern of 
the RLC-A 3'-untranslated region probe (333 nt Alu I/Eco RI 
fragment), shown in Fig. 3 b, demonstrates that the RLC-A 
mRNA is detected in all of  the same tissues. However, RLC-A 
mRNA is most abundant in lung, uterus, aorta, and sarco- 
meric tissues. 
Direct comparisons of the relative abundance of RLC-B to 
RLC-A mRNA populations,  shown in Fig.  3 c, were per- 
formed after hybridization of the 524 nt Eco RI/Pst I frag- 
ment containing only the common amino acid coding se- 
quences and 15 nt of 5'-untranslated sequence (see Fig. 2 a) 
on duplicate RNA blots of rat tissues generated from gels 
using identical electrophoresis conditions as in Fig. 3, a and 
b, of rat tissues (see Materials and Methods). Despite the in- 
ability to completely resolve the two hybridizing species due 
to the similarity in electrophoretic mobility, the autoradio- 
gram confirmed the impression that RLC-A and B mRNA 
populations are similarly expressed in spleen, kidney, lung, 
and  uterus  but  quantitatively  expressed  differentially in 
brain, aorta, and sarcomeric tissues. Therefore, the expres- 
sion pattern of neither mRNA population can be described 
as smooth muscle specific. 
To establish the integrity of the RNA and to correlate the 
expression of RLC-A and B with actin gene expression, hy- 
bridization was performed using a  skeletal muscle a-actin 
coding region on the same RNA blots. This probe crosshy- 
bridizes at moderate stringency with both the f3/7 actins (cy- 
toplasmic actins) and with the o~-isoactins (smooth and sar- 
comeric isoactins). As can be seen in Fig.  3 d, the tissues 
expressing abundant amounts of muscle ot-actins are also the 
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Figure 2.  Sequence analysis of the RLC-B  clone.  (a) Complied 
nucleotide sequence of RLC-B  (lower line)  compared to the se- 
quence of RLC-A (top line) (46). Lower case letters represent the 
corresponding 5' and Y-untranslated  sequences and capital letters 
represent  the open reading  frame of the amino acid coding se- 
quence. The start (ATG) and the stop (TGA) codons are in bold let- 
ters. Colons represent sequence identity between the two sequences. 
The polyadenylation sequences are underlined. The 47 nucleotide 
repeat  located in the Y-untranslated  region of RLC-B is in bold 
lower case letters. The location of the Pst I and Alu I restriction 
same  tissues  expressing  the  most  abundant  quantities  of 
RLC-A except in the case of lung in which a-actin is not de- 
tected.  In  contrast,  those  tissues  with  abundant  RLC-B 
mRNA alone, such as brain and spleen, do not have detect- 
able a-actin mRNA present. 
The correlation of the expression of RLC-A and B with the 
smooth muscle specific exon 2 of ct-tropomyosin  was deter- 
mined. The rat o~-tropomyosin is encoded by a single gone 
whose transcript  is alternatively spliced to produce distinct 
nonmuscle, smooth and striated muscle isoforms (55). Exon 
2 of ot-tropomyosin  is expressed exclusively in smooth mus- 
cle cells and, to date, has not been detected in any other cell 
type (reference 55; B. Nadal-Ginard, unpublishedobserva- 
tion). The t~-tropomyosin probe was generated by producing 
a cRNA probe using a unique Xho I site and yielded a 125 
nucleotide transcript  that  was hybridized to the rat tissue 
RNA blot. The autoradiogram shown in Fig. 3 e confirmed 
that the expression of the smooth muscle-specific exon 2 was 
restricted  to  uterus  and  aorta.  Low  levels  of detectable 
mRNA was seen in all of the tissues after overexposure of 
the blot consistent with vascular content of these tissues. The 
comparison between RLC-A and B confirmed that,  unlike 
the c~-tropomyosin exon-2, neither RLC-A or B are smooth 
muscle specific. 
RLC-A and RLC-B mRNAs Are Also Expressed 
Differentially in a Variety of CeU Lines 
The presence of RLC-A and B mRNA in all tissues examined 
strongly suggests that these two genes are expressed in cells 
other than smooth muscle cells. It is possible that some of 
the expression of RLC-A and B mRNA is derived from vas- 
cular cells present in these tissues. The fact that the smooth 
muscle-specific  exon  of  c~-tropomyosin  is  not  detected 
makes this  extremely  unlikely.  To further  investigate  this 
possibility,  we have  examined a  variety  of cultured cells, 
many  of which do  not  contain  smooth  muscle  elements. 
Furthermore, the expression of RLC-A and B in these non- 
smooth muscle cells can be contrasted with expression of 
RLC-A and B in smooth muscle cells. 
Cultured  RASM  after early  passage  are phenotypically 
modulated and morphologically resemble the fibroblasts and 
smooth muscle cells of the immature aortic wall (42). These 
cells undergo changes in contractile protein gene expression 
in response to differing culture conditions (15, 21). For ex- 
ample, Owens et al. (37) have demonstrated increases in the 
level of smooth muscle oMsoactin  in response to serum de- 
privation and/or confluence. Fig. 4 a is an RNA blot analysis 
of total cellular RNA from RASM cells at varying  degrees 
of confluence (lanes I-3) and during serum deprivation (lanes 
sites are underlined and labeled to demonstrate the sites used to 
generate 3' untranslated  region-specific probes. (b) Comparison of 
the amino acid sequences of the four known sequences of nonsarco- 
meric RLCs. Abbreviations: ChG RLC, chicken gizzard (31); HuV 
RLC, Human Vein RLC (25). Sequence identity is shown by dash 
lines. (c) Alignment of the 47-bp repeat in the 3' untranslated  se- 
quence of RLC-B is shown with the corresponding nucleotide num- 
bers shown in the right and left margin. These sequence data are 
available  from EMBL/GenBank/DDBJ  under  accession number 
X52840. 
The Journal  of  Cell  Biology,  Volume 11  I, 1990  1130 Figure 3. Rat tissue RNA blots. The position of  the 18s RNA 
is shown to the right. The position of  the RLC-A and RLC-B 
mRNA populations is highlighted by an arrow in each panel. 
(a) RNA blot hybridized with a cRNA probe generated from 
the 3' untranslated sequence of RLC-B. (b) Duplicate RNA 
blot hybridized with a cRNA probe generated from the 3' un- 
translated sequence of RLC-A. (c) Duplicate RNA blot hy- 
bridized with a cRNA probe containing only the ceding re- 
gion  of  RLC-B  that  crosshybridizes  with  both  mRNA 
populations and, to a lesser degree, the LC-2 of sarcomeric 
tissues (lane 8). (d) RNA blot probed with the coding region 
of human u-skeletal actin eDNA. This RNA blot was previ- 
ously probed with the RLC-B-specific 3' untranslated region 
was reprobed showing the characteristic sizes of the cross- 
hybridizing cytoplasmic actins (B/3') and the muscle t~-iso- 
actins (~). Tissues used include: (1) liver; (2) spleen; (3) kid- 
ney; (4) brain; (5) lung; (6) uterus;  (7) aorta;  (8) heart. 
4 and 5 only). These duplicate blots clearly support that un- 
der varying growth conditions, including growth and growth 
inhibition,  both RLC-A and RLC-B are abundantly expressed. 
The pattern of expression of each RLC isoform does not 
resemble oMsoactin that goes up in similar conditions. 
To rule out that the detection in sarcomeric RNA of the 
two RLC mRNAs was because of the presence of vascular 
smooth muscle, RNA from the C2C12 mouse skeletal myo- 
blast cell line was  analyzed.  As  can be seen in  Fig.  4  b, 
(lanes 3  and 4),  when the coding region probe was used, 
RLC-A mRNA was easily detectable; however, no detect- 
able RLC-B mRNA was seen. To ensure that the absence of 
RLC-B mRNA in the mouse cell line was not due to the in- 
ability of  the rat probe to recognize mouse RNA, mouse NIH 
3T3  fibroblasts were examined by RNA blot analysis and 
were  found to  have abundant  amounts  of RLC-B  mRNA 
when either the RLC-B 3'-untranslated region probe or the 
limited coding region probe were used (data not shown). In 
addition,  the  process  of differentiation and  fusion  of the 
C2C12  cells was  associated with  minimal  changes  in  the 
RLC-A mRNA.  C2C12 differentiation was confirmed by a 
decrease in cytoplasmic actins and a corresponding increase 
in the muscle-specific tx-isoactin mRNA content after fusion 
(Fig. 4 b, lanes 5 and 6). It must be noted that the RNA con- 
tent of the actin mRNAs  cannot be directly related to the 
RNA  content of the  RLCs because different probes were 
used (the actin probe was  random-primed eDNA and the 
RLC was a cRNA probe that has been through washes and 
rehybridization resulting a decrease in the signal). In BC3H1 
cells, a nonfusing mouse muscle cell line that biochemically 
differentiates into a skeletal-like cell line (48), RLC-A mRNA 
was  in  much greater abundance  than the  RLC-B  mRNA 
(data not shown). In both the rat hepatoma line (H4TG) and 
the rat pancreatic acinar cell line (AR42J) (Fig. 4 b, lanes 
I  and 2), the amount of RLC-B mRNA detected was greater 
than the RLC-A mRNA. The pattern in these two nonmuscle 
cell lines is similar to the pattern observed in nonmuscle tis- 
sue types such as spleen, brain, and liver in which RLC-B 
mRNA is also more abundant.  This data suggests that cell 
lines and in particular those used to study muscle gene ex- 
pression in vitro, mimic the in vivo expression pattern of the 
two RLC mRNA populations and is not due to vascular con- 
tamination. 
Isolation and Characterization of  RLC 
Genomic Clones 
Screening of a  rat liver genomic library with the RLC-A 
cDNA yielded 16 positive clones. Restriction mapping and 
Southern blot analysis revealed the presence of three defina- 
ble loci (RLC gene A, RLC gene B, and a pseudogene), in 
addition to a  group of unrelated homologous clones.  The 
boxed enlargement  in  Fig.  5  a  shows  the  details  of the 
genomic organization of RLC-A.  The gene spans  •7.5  kb 
and is divided into four exons and three introns. The nucleo- 
tide sequence is shown in Fig. 6. The site of transcriptional 
initiation, as predicted by primer extension analysis, is 24 
bases upstream from the corresponding sequence of the end 
Grant et al. Mammalian Smooth Muscle Regulatory  l_z'ght Chains  1131 Figure 4. RNA blot analysis of RLC-A and B expression in rat and mouse cell lines,  (a) RNA blot rat aortic cells 2, 3, and 5 d after 
passage are shown in lanes 1-3. Lanes 4 and 5 show the expression pattern 24 and 72 h after withdrawal of serum. The 3' untranslated 
region of  RLC-B and RLC-A were used with duplicate RNA blots. (b) RNA blot of  cell line RNA probed with the coding region (nonspecific 
RLC probe) cRNA of RLC-B. Lane 1, H4TG rat heptoma cell line; lane 2, AR42J rat pancreatic acinar cell line (poly-A+  RNA); lane 
3, C2C12 mouse undifferentiated myoblast cell; lane 4, C2C12 mouse differentiated myotubes; lanes 5 and 6 represent lanes 3 and 4 after 
probing with the skeletal actin probe without striping. 
of the RLC-A eDNA (in reference 46; see Fig. 9 underscor- 
ing at + 1 ), yielding a first exon of 93 nucleotides. This start 
site is shared by cell types representing nonmuscle, smooth 
muscle, and sarcomeric tissues (46).  The genomic nucleo- 
tide sequence immediately upstream from this region does 
not contain a  TATA-like sequence.  However, the region is 
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Figure 5.  The partial restriction map of the RLC genomic locus. 
(a) Combined partial restriction maps of genomic clones (GRLC) 
2, 3, and 17 are shown. The designated RLC-A gene (underA) con- 
taining  the  restriction  fragments  corresponding  to  the  RLC-A 
eDNA are represented by the striped boxes. The 305-bp Sal I/Eco 
RI homologous fragment (under  B) is represented by the solid box. 
Restriction enzymes are represented as: B, Bam HI; R, Eco RI; H, 
Hind 11I; N, Nco I; P, Pst I; S, Sal I. The boxed insert contains an 
enlargement of the restriction map of the RLC-A gene with exon 
organization represented with the numbers of corresponding to the 
nucleotide sequence of  the RLC-A eDNA shown; +1 represents the 
start codon ATG. (b) The partial  restriction  map of overlapping 
genomic clones 7 and  18 is shown. The boxed insert contains an 
enlargement of the identified RLC-B pseudogene and the position 
of the ATG and TGA codons. 
overall GpC rich resembling constitutively expressed pro- 
moters such as HMG-CoA reductase (40),  mammalian di- 
hydrofolate reductase (31) and o~-tropomyosin (55). Sequence 
comparison of this region with the 5' flanking region of the 
ot-tropomyosin gene (55), which also lacks a TATA-like pro- 
moter region, reveals "-60% sequence identity between nu- 
cleotides -100 and -200. Such homology suggests that this 
region might interact with transcriptional regulatory factors 
involved in the expression of these genes. 
The Genes Coding For RLC-A And RLC-B Are 
Closely Linked 
One  genomic  clone  (GRLC-17)  contained  two  restriction 
fragments with homology to RLC sequences when analyzed 
by Southern blot analysis using the RLC coding region as a 
probe. The first, a 5-kb Eco RI/Sal I fragment is the RLC-A 
gene including its 3'-untranslated sequence (Fig. 5 a, striped 
boxes),  The second is a 305-bp Eco RI/Sal I fragment (Fig. 
5 a, solidbox). This fragment has an identical nucleotide and 
amino acid sequence to the RLC-B eDNA and contains an 
open reading frame in the same 5' to 3' direction as RLC 
Gene-A (Fig. 7). Comparison of this genomic sequence with 
the corresponding sequence of the RLC-A gene (distal por- 
tion of intron 1 and the 5' most sequence of exon 2) demon- 
strates that the sequence diverges at the same site of sequence 
divergence in the 5'-untranslated regions of the RLC-A and 
RLC-B cDNAs (Fig. 2) and a RLC-B processed pseudogene 
(restriction map shown in Fig.  5 b  and unpublished data). 
The Y-flanking sequence of this genomic RLC-B, which pre- 
cedes the open reading frame, contains a poly-T-rich tract 
followed by an "ag" which is consistent with a splice site ac- 
ceptor consensus sequence (32). After codon 31 the two se- 
quences diverge with a "gt" present in the reading frame cor- 
responding with a splice donor site. The absence of sequence 
conservation  between  the  flanking  DNA  of this  putative 
RLC-B gene and any of the introns of RLC-A makes it un- 
likely that  this  sequence  is  a  pseudogene  composed of a 
duplicated portion of the RLC-A gene. Such types of pseu- 
dogenes usually contain portions of both introns and exons 
of the parent gene (52, 54, 56). We propose, based on these 
sequence  characteristics,  that  this  linked  partial  RLC  se- 
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ggccaaagaggeagcgtgg~cc  tgaaae  t t tagtat tccgt  c¢¢gcgtgggaaaagtgaggagctat  t t t aaaat t eat t  -489 
t  t  catac  t  t  t  t  cgagt  tgc  tcgcacat  ccct  tcc~cgccg~gagacactgaceeacaggc  tgat  tc~cact  agt  t  t¢c~g  -40~ 
~g~aggg~atgc~gaaut~ag~gag~gggag~ccgggctggggag~gggg~caaggctagtcag~gtgagacccgtgg  -329 
~a~tt~aca~t~aattt~taaatg~8~ttagaggggtt~cg~t~t~acca~g~tgttta~t~tg~a~a~ct~ctgg  -249 
agagc  cannngggaggaagcagaa  t cacag t t ceaaacggagacgcgagaaagacgaagagt~cagtatat  tagaccaga  -t69 
agaggt  oct  ceacacgtccat t teagccctaaactccccgt t cggtae  t t croat cgegccctgaeggcgcca  t c tgct  c  -89 
t gacacc t t tee t gaggt  ccccc t cccg t caggg¢  tggccca  t agaggcggcggagaa  t ggcgccagg¢  t t c t t cegg  t t  -9 
tKcgaE~tgg~cEt~:e~t~O~GCGGCAAAGCTTCGCAGAGACGCTCACT~GT~:CTCGcGGC!~  +72 
AGCAGGgtgagtggtgctggcctgcgaegcgt  t tgg~getgcgt  ccg~ctaacgt  t t t t cct c¢cgt  ctatat t caaaag  +182 
gacgcagaagt  t ca t ¢aggat  ¢ggt  ~acaacat cggcaag  t ~gcgt  t aacca~ tct t e t c t gga  tggggtat t t aggg  t t  *232 
acaatatgcgcccattttgcttgtagetaccaattggeaaattteagagggcettatgg  (---t,7kb---)  gtttc  ~1996 
c t c t tgat c¢ t tg  t agaa taagga¢¢at  t ¢ tgaa¢  tgtcagtgt t tga  tga  t agggt  e t caatgtgtgccc t tggct  ce t  -20?6 
~agc~acaggt~g~tg~t~ca~tgttggg~tta~A¢agtca~a~¢ac~c~ttca~tt~ttc~tc~a~ttta~  -2156 
goat  tgt t t t aact tgagagt  cat tcctctggaatgggggaagtgtgtagct cat tgcctaagt tgAgccaatcat  t tac  -2236 
tt~at~tgtctct~tgtgttttaa~tgtt~tttaagatgagtc~a~atgtt¢~tg~agtga~attg~tat~a  -2316 
t caatataa t tagctggt cctaatacagt tgaat  taagtatggaat tct t c t tecggt tgtgaa~¢  ta~tgt taatgeta  -2396 
aataaaact tct t t tcaactgt t t tataatgcat t tgctaat t t t taaatgcacgct t taagtaataagatatatat  tat  -2476 
taaaaa tea tg  t tae t t t taaca t t t taagea  t t t ta t aaaggaat  t t baacag  taccceateaaa tgtag t t t taca  tg  -2556 
aaa t t t tg  tagac  taaaaaa t t t cgaac g tcg  t cggc  t a t t t tee  tggg  t ta t t gggcaaggaagac~aga  t taga  tcca  - 2636 
tataaacaggctatttttgaagattttttgcccttgeaaggcat  (-'l*3kb--)  ttagtcaccccgctccaaceca  "4002 
agcaaaccc t c t tgt t tact t tgt t tgt tactgagcgetg tctggt ggtgggga  ta tgtaatc t t tga  ta tgc tgt t tgc  -4082 
t t tgagtggat  gt taa teggaatcc t ta¢ tggaaaaaagac  t t tcaac t t t taagagcgagtaaactcaaagctc t agac  -4162 
tggt t t tc¢ct t t t agt  t tggt  t g ~  ~ggffatgaaat  t ~  t t acagt t a tgc~ceccac tgaga~a  t ggctztgacc~atag  -~2A2 
tct cagtcgtagt ctcagt cgtatgtaaagacaat t ceac t t tat t t t tgt t aatcat tat tggtgat t ccatact tagt  -4322 
aatettaggtaetgattttaattecgaattcttccaatt~ATTTAACCGCCACC  ATG  TGG  AGC AAA AGA  t*~'G -4396 
(I)  ~  S  S  it  R  A 
AAG AL~ AAG ACC A~  bAG AAG C~C CCT CA~ CGC GCA ~CG TCC AAC GTG TTC GCC ATG TTT  ~4456 
K  T  K  T  T  g  K  R  P  Q  R  A  T  S  N  V  F  A  M  F 
~AC C~  TeC tAG AT~ CAG ~A~ TT~ AAA Cd~ ~CC ~  ~AC ATG ATC GAC C~  AAC ~  ~  ~4516 
D  Q  $  O  I  0  g  F  K  It  A  F  N  ~  I  D  ~  ~  R  O 
GG~ TTC ATC C,  AC  ~  GAG  ~  CTG  CAC GAT AT{;  ~  GCT TCA ATG G~taatgttceacttgce,  g  -4580 
~  I  B  K  E  D  L  B  D  M  L  A  S  8 
(61) 
tgc  tgatgt  a  t  tgcatagaat t  tcct  t  cat  t  c  t  t  t  t  cgtgaaAcagcct tg  t  t  tccc  t  cgatgggt taectgtetc tcg  ~4660 
gg  t tggac  tggaggc  tgt  gt  gtgt c tgcat tcc t aca tggatgtggg  t tggtg  t t t gagaaagtga~ggctgv4g  t ggt  -4740 
tgc  t eagaga  t aagagtg~at  gc  tg¢~: tgeac~gagagggt  tggggt  t agtg~ccagea¢  tcg  tg  t t c~gt  a~ t c tgca  -4~20 
gccc  t  gcttcca~cce  t  t  tagat  t  c  t  c  tggggac  tgcat  t  cagcta tgct  act  tagct  t  t  tce  tgt  ca  tgaaa~ccea tg  -4900 
atagcggt t t tat t t tccactagaatgt t taccatgat taataat tggaatat t tceaacgtgt tgtgagtgtgcct ett  -4901 
G  K  ,,  --  T  D  E  --  L  O  A  Is  ~  N  •  A 
(62) 
CCC ATC ~AT TrC ACC AT~ TTC CYC ACt:  AT~ TIT G~A ~A~ AAG CTa bAC ~C  ACC GAC COT  -5023 
F  I  N  F  T  M  F  L  T  R  F  G  R  g  L  N  G  T  D  P 
GAG CAC GTC ATC AGA bAT ~CC TTC GCT TGC TTc GAT GAG G/k%  (;CA  ATC Ggtagceggggtaa¢  -5086 
E  D  V  I  R  N  A  F  A  C  F  D  g  E  A  I 
ttt  (-'t,Skb--~  tecatcttecetecagC-C ACC Age CAG ~  GAT TAC ~  AG~ GAG ~  CTC  ~6642 
(n6) 
ACC ACC ATG GGC GAC CCC TTC ACA CAT GAG GAA GTG CAT GAG CTG TAC A~G GAG GCC CCC  -6702 
T  T  ~  G  D  R  F  T  D  E  D  V  D  £  L  Y  R  g  A  F 
AlC ~AC ~  ~  ~  AAT ~  AAC TAC &'l~  GAG ~  A~  C~  AIX; ~  ~AG O,C ~  ~;~  -6762 
I  D  K  K  G  l't  F  N  Y  I  E  F  T  It  ~  L  g  ~  G  A 
AAA GAC AAA CAT GAC TCUt~GAGCTGTG6CTTCCAGCCAAATGTCCCTGTTGCCATTGGGTCCTCCTGGAGCGGTC  -6837 
K  D  K  D  D  * 
(I72) 
GGCT••CCTTGCTTTTCTG•CTTTTGCTTCCCTTGTTTTGTATTTATTCTCAGCCACTTTGGG•CA•GTGTACCTTCATC  -6917 
ATCAGAG~GGAAACGGGACTTTC~GTCATTGTTCGATGAGbACGTbAGGTAATTrAAC~TA~AGAC~GTCTTGT~CCTT~  -6997 
T  AATAACTGCAGCCACAGA~1"CAGTATATT1Tr.~`CAGA~AAAGTTATCCACTCAATTTTTTCTGAATGATAATTA``~CTT  *7077 
TCTGATAAAAtact  tagt tgt t tagcc t tct t tccc ~ac t tgact t t tagt t ~  t accgagt  ct t t c¢ccaagcagggtag -7157 
at~aggtgaatga~ag~tgt~agag~ttgct~ca~tcttcagttgtgttt~agttgtgttt~¢a~gg~a~t¢~ag  -7237 
t t tact ct  actcctagt t tat t c tct ctctcce t ~ctggaaa  t ¢aagat  aaage t cot tgggta¢ceaagac~  t tgt  ¢ t t  ~7317 
ccagt t tggaaaataaggcctgaat tct cgatccc tggggt  age tcagac t cccct t aaacgt¢ t c t ctgcat tact t cc  -7393 
tgcag-3'  -7398 
Figure 6.  Nucleotide sequence of the rat RLC-A gene. The se- 
quences of the exons (from RLC-A cDNA) are in upper case letters. 
Numbering is based upon the predicted site of transcription  as +1. 
The derived amino acid sequence is represented by the single letter 
code in bold upper case letters. Potyadenylafion sequence is under- 
lined. The region of homology to the 5' flanking  sequence of the 
rat a-tropomyosin gene are in lower case bold letters (between -200 
and -105).  Sizes of the tmsequenced regions are based upon es- 
timates from the restriction mapping. These sequence data are 
available  from EMBL/GenBank/DDBJ  under accession  number 
X53593. 
quence represents the rat RLC-B gene. Absolute proof of this 
linkage should be provided by complete characterization of 
the entire RLC-B genomic locus. 
Discussion 
We report the identification and characterization of myosin 
RLC  eDNA  with  novel  sequence  and  expression  pattern 
from those previously described. This cDNA contains a 570 
nucleotide open reading frame that is 94% homologous to 
the corresponding sequence of our previously reported RLC 
cDNA  (RLC-A)  isolated  from RASM  (46).  The derived 
amino acid sequence contains only 5  amino acid changes 
from the RLC-A and 10 amino acid changes from the chicken 
gizzard smooth muscle RLC protein sequence (28, 29) iden- 
tifying it as a smooth muscle type of RLC. 
Our data using the specific Yuntranslated region probes 
from the rat cDNAs reveal that the expression of RLC-B can 
be correlated with the distribution of the cytoplasmic actins. 
This is in contrast to the expression of RLC-A which is most 
abundant in muscle cells. Neither of the rat RLC genes can 
be described in a strict analysis of tissues and cell lines as 
smooth muscle specific. Kumar and co-workers have reported 
a eDNA isolated from human umbilical vein that is expressed 
in abundant amounts in umbilical artery, colon, and uterus 
but is absent in cardiac and skeletal muscle tissues (25). This 
same mRNA is detected in human ceil lines including fore- 
skin fibrobtasts,  the human lip diploid fibroblast  (kD) cell 
line and fetal lung fibroblasts.  Its expression in a wider sur- 
aLCott  5t-~tct  ~ae¢¢teta~e  23 
RLe-A  5, -gegegt  aaact e~agct ¢ taga -4161 
RLe-B  caall~ ~  t e¢ r tat t t~gt at  t t t t ae t etage  tggcat  ¢4¢/~et tttalt  t t ee~ggccagecgggt  t~ecegaata~c¢¢  103 
I~LC-A ~tggtttt~cttttagtttggtt~ttgggatgaa~ttttta¢agttatt~cgc~a~tg~q~a~atg~t~tE&¢caat8  ~4241 
tKL0-,~ cgt~6tate,  aa~aaageJlagaAaaagAt  t t t tat  t tat  t t~tetgt tat  t ~at  t tatetgt et  tagatgtgtatg~¢etc  183 
gL~,-A gt~t~agt~gtagt~tcagt~gtatgtaaagacaatt~a~tttatttttgttaatcattattggtgatt~ata¢ttag  ~4321 
gLC-~  teKc  ~  t ~*tegt ~C  t~tgea  t tgt  t t t Cgt  t~t  tat t t t ~31~-at t tga~eegecaccA~N-~  "  ~A  ~62 
gLC+A taatcttaggtaetgattttaattcegnattettceaatt~tt~.gatttaaecgcea~eA~'r~GA~eGAge4tH  S  S  K  R  A  K  ~6400 
.........................  It  * 
ALe-8 ~ACCA~  _  £r~a-t~,~eCAqreOe~A~  t g~e  c t  342 
RLC-A Y--t4GA(:~  ~GT~F£Y-,,(Z~*IGT'FF-.~TAGI'~C~CaTO~AGGA~bTT~  -4~8D 
T  K  T  T  K  Kit  P  0  RAT  $  ~  V  r  A  Pl  F  D  ~  $  0  ~  0  E  F 
RLC-B  geagg~POLYLIN~ER  352 
RLC-A AA~CA~C.ATC~TCGAI~:A~,t~CO~GGA~CA,TC~A~C~.ACr.~TATG~T  -4560 
K  E  A  F  ~  ~  I  DO  N  R  D  G  F  I  D  K  R  D  L  H  D  ~  L  /t  $ 
RLC-,A GG gtaatgttccacttgcagtgetgatgtattgcatagaatttcctteattettttegtgaageagccttgtttceete  ~4539 
Ngure 7. Nucleotide sequence of the linked RLC gene. The 305-bp 
Sal I/Eco RI fragment of GRLC-17 is shown 0ine RLC-B) com- 
pared to the nucleotide sequence of RLC-A gene (line RLC-A) with 
the derived amino acid  sequences,  nucleotide  homologies,  and 
amino acid homologies as in Fig. 1. The restriction sites (see Fig. 
5, under B) are shown above the RLC-B nucleotide sequence. The 
numbering of RLC-B starts with I at the Hind HI site. The nucleo- 
tide sequence of RLC-A is Fig. 6. The polylinker represents the site 
of the phage arm from which this fragment was suhetoned. The "gt" 
consistent with a splice donor site at the beginning of an intron and 
the consensus sequence of splice acceptor sites are underlined. An 
additional  arrow and a gap in the sequence represents the site of 
the splice site donor site of RLC-A gene from Fig.  6. These se- 
quence data are available from EMBL/G-enBank/DDBJ  under ac- 
cession number X53594. 
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also expressed in cells that are not smooth muscle. 
The differences between subtypes of nonsarcomeric (i.e., 
smooth muscle and nonmuscle) myosins are minimal. The 
nucleotide sequence data of the specific myosin isoforms of 
smooth and nonmuscle contractile proteins reveal the use of 
either virtually identical isoforms as in the cases of alkalai 
light chains (26,  33) and the myosin heavy chains (34), or 
extremely homologous isoforms as in the case of the regula- 
tory light chains. The chicken gizzard myosin RLC is the 
most studied vertebrate nonsarcomeric RLC and its function 
is quite different  when compared to the sarcomeric RLCs (2, 
9,  16, 39).  Functional differences between chicken gizzard 
RLC and nonmuscle RLCs are more subtle (3, 6, 8, 9, 23). 
A potential structural basis for a functional difference be- 
tween chicken gizzard RLC and RLC-B may exist at amino 
acid 5 where a lysine is substituted for an arginine. Synthetic 
peptides have been used as substrates to study the efficiency 
of phosphorylation by myosin light chain kinase and protein 
kinase C (18, 22). Kemp has determined the importance of 
basic residt/es between positions 8 and 19 in the specificity 
of the myosin light chain kinase from smooth muscle (22, 
38). However, the longest peptides used did not include the 
first 7  amino acids from the NH2-terminal position. In a 
similar approach, Hassell has determined that the peptides 
lacking Lys-4 and Arg-5 are important in determining the 
substrate efficiency of phosphorylation at Thr-10 by protein 
kinase C  using synthetic peptides up through position  13 
07). This strongly suggests that the substitution of Lys for 
Arg at position 5, as occurs in RLC-B, may have a significant 
effect on the function of the RLC within cells. The availabil- 
ity of the two RLC cDNAs will permit expression of these 
proteins and the determination of their properties as sub- 
strates for phosphorylation by myosin light chain kinase and 
protein kinase C. 
The data obtained with the RLC-A and B probes reveal 
that, despite being homologous proteins, they are genetically 
quite distinct.  The 3'-untranslated regions of each cDNA 
corresponds to different mRNA populations. Despite the co- 
expression of the two mRNAs, the genes clearly have differ- 
ent expression patterns when the various rat tissues are com- 
pared. The genomic structure of the gene encoding RLC-A 
(four exons and three introns) is less complex than the struc- 
ture of the other members of the calcium-binding supergene 
family (43).  The promoter region has the sequence charac- 
teristics of many constitutively expressed genes with the ab- 
sence of a TATA sequence adjacent to the mRNA start site. 
In addition, the gene for RLC-B appears to be linked to 
RLC-A gene. This linkage focuses attention on the intergenic 
region if transcriptional regulation is present. Despite the ex- 
tensive screening of multiple cDNA libraries, we have not 
found any evidence for additional RLC isoforms. The pro- 
tein data available to date (11) supports the existence of only 
two isoforms, though, a third isoform that might be smooth 
muscle-specific may exist based on the immunohistochemi- 
cal analysis by Kumar (25). 
The presence ofa RLC multigene family made up of mem- 
bers with marked sequence conservation, both within the 
same species and across species, serves to emphasize the im- 
portance of the phosphorylated 20-kD myosin RLC in cellu- 
lar contractile processes. The complicated expression pat- 
tern points  to  subtle  differences between nonmuscle and 
smooth muscle cells on the genetic level and confirms the 
need to further define the molecular and genetic level and 
confirms the need to further define the molecular and genetic 
basis of the contractile phenotype in smooth and nonmuscle 
cells. 
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